Related references
Note: Only part of the references are listed.Management of Severe Neuropathic Cancer Pain: An Illustrative Case and Review
Irene Connolly et al.
AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE (2013)
The Potential of Pregabalin in Neurology, Psychiatry and Addiction: A Qualitative Overview
Giovanni Martinotti et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
A Comparative Efficacy of Amitriptyline, Gabapentin, and Pregabalin in Neuropathic Cancer Pain: A Prospective Randomized Double-Blind Placebo-Controlled Study
Seema Mishra et al.
AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE (2012)
The Relationship Between Cancer Pain and Quality of Life in Patients Newly Admitted to Wuhan Hospice Center of China
Di Deng et al.
AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE (2012)
How is neuropathic cancer pain assessed in randomised controlled trials?
Geana Paula Kurita et al.
PAIN (2012)
Which domains should be included in a cancer pain classification system? Analyses of longitudinal data
Anne Kari Knudsen et al.
PAIN (2012)
Interviews with patients with advanced cancer-another step towards an international cancer pain classification system
Anne Kari Knudsen et al.
SUPPORTIVE CARE IN CANCER (2012)
Pharmacological Treatment of Neuropathic Cancer Pain: A Comprehensive Review of the Current Literature
Athina Vadalouca et al.
PAIN PRACTICE (2012)
First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the On study
M. L. Garcia de Paredes et al.
ANNALS OF ONCOLOGY (2011)
Post hoc analysis of pregabalin vs. non-pregabalin treatment in patients with cancer-related neuropathic pain: better pain relief, sleep and physical health
Ana Manas et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2011)
Which variables are associated with pain intensity and treatment response in advanced cancer patients? - Implications for a future classification system for cancer pain
Anne Kari Knudsen et al.
EUROPEAN JOURNAL OF PAIN (2011)
A prospective open-label trial of gabapentin as an adjuvant analgesic with opioids for Japanese patients with neuropathic cancer pain
Hidenori Takahashi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2010)
Low-dose gabapentin as useful adjuvant to opioids for neuropathic cancer pain when combined with low-dose imipramine
Young-Chang P. Arai et al.
JOURNAL OF ANESTHESIA (2010)
Gabapentin for the Treatment of Cancer-Related Pain Syndromes
Voichita Bar Ad
REVIEWS ON RECENT CLINICAL TRIALS (2010)
Management of Neuropathic Cancer Pain Following WHO Analgesic Ladder: A Prospective Study
Seema Mishra et al.
AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE (2008)
Pregabalin: Its pharmacology and use in pain management
Noor M. Gajraj
ANESTHESIA AND ANALGESIA (2007)
Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)
D Bouhassira et al.
PAIN (2005)
Pregabalin - In the treatment of painful diabetic peripheral neuropathy
JE Frampton et al.
DRUGS (2004)
Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia:: results of a randomised, placebo-controlled clinical trial
R Sabatowski et al.
PAIN (2004)
A randomised controlled study on the use of anti-inflammatory drugs in patients with cancer pain on morphine therapy: effects on dose-escalation and a pharmacoeconomic analysis
S Mercadante et al.
EUROPEAN JOURNAL OF CANCER (2002)
Morphine and alternative opioids in cancer pain: the EAPC recommendations
GW Hanks et al.
BRITISH JOURNAL OF CANCER (2001)
Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons
P Honore et al.
NEUROSCIENCE (2000)